Black Diamond Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.
BDTX Key Statistics
Stock Snapshot
With a market cap of 131.84M, Black Diamond Therapeutics(BDTX) trades at $2.30. The stock has a price-to-earnings ratio of 5.48.
As of 2026-04-01, Black Diamond Therapeutics(BDTX) stock has fluctuated between $2.16 and $2.38. The current price stands at $2.30, placing the stock +6.5% above today's low and -3.3% off the high.
The Black Diamond Therapeutics(BDTX)'s current trading volume is 697.32K, compared to an average daily volume of 490.94K.
In the last year, Black Diamond Therapeutics(BDTX) shares hit a 52-week high of $4.94 and a 52-week low of $1.20.
In the last year, Black Diamond Therapeutics(BDTX) shares hit a 52-week high of $4.94 and a 52-week low of $1.20.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.